Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplastic disorder, characterized by recurrent nosebleeds (epistaxis), multiple telangiectases and arteriovenous malformations (AVMs) in major organs. Mutations in Endoglin (ENG or CD105) and Activin receptor-like kinase...
Main Authors: | Daniela S. Ardelean, Michelle eLetarte |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-02-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fgene.2015.00035/full |
Similar Items
-
Contribution of Oxidative stress to Endothelial Dysfunction in Hereditary Hemorrhagic Telangiectasia
by: Mirjana eJerkic, et al.
Published: (2015-02-01) -
Biomarkers for Anti-Angiogenic Therapy in Cancer
by: Markus Wehland, et al.
Published: (2013-04-01) -
Old Player-New Tricks: Non Angiogenic Effects of the VEGF/VEGFR Pathway in Cancer
by: Panagiotis Ntellas, et al.
Published: (2020-10-01) -
Teaching immunology as a science and field of medicineA book review of Immunology IV, Clinical Applications in Health and DiseaseEdited by Joseph A. Bellanti, Georgetown University School of Medicine, Washington, DC: I Care Press, Bethesda, Maryland, 20816, 2012, 1063 pages.ISBN: 978-0-692-01160-7
by: Michelle eLetarte, et al.
Published: (2014-03-01) -
Potential Second-Hits in Hereditary Hemorrhagic Telangiectasia
by: Carmelo Bernabeu, et al.
Published: (2020-11-01)